Joffrey Feriel: Comprehensive Review of Laboratory Assays for von Willebrand Factor and Associated Disorders
Joffrey Feriel, Associate director of medical affairs at STAGO, shared a post on LinkedIn about recent articles by François Depassea et al, adding:
“A myriad of laboratory assays, from first line to esoteric assays, exist to enable adequate diagnosis of VWD and other diseases influenced by VWF.
Choosing the right test for the right situation can be tedious and DIN members are helping us with this task by publishing two excellent review articles.
The first article provides a comprehensive overview of all relevant assays with their technical features, analytical performance and availability for research and clinical purposes.
The second article focuses on the use of these assays for the diagnosis of VWD, acquired von Willebrand syndrome, and for thrombotic risk assessment.
Congratulations to Francois Depasse, Nikolaus B. Binder, Mariona Bono Illa, Matthias Germer, Michael Heins, Martina Leplatoni, Patzke Juergen, Stephan Schwers, Michael Spannagl, Peter L. Turecek.”
Title: Review of laboratory methods used for analysis of von Willebrand factor and for diagnosis of related diseases
Authors: Jürgen Patzke, Nikolaus B Binder, Mariona Bono, François Depasse, Matthias Germer, Michael Heins, Martina Leplatoni, Stephan Schwers, Michael Spannagl, Peter L Turecek
Read the Full Article on Expert Review of Hematology.
Title: Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches
Authors: François Depasse, Nikolaus B. Binder, Mariona Bono, Matthias Germer, Michael Heins, Martina Leplatoni, Jürgen Patzke, Stephan Schwers, Michael Spannagl, Peter L. Turecekb
Read the Full Article on Expert Review of Hematology.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS